+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United States Gene Editing Technology Business and Investment Opportunities Databook - Q2 2023 Update

  • PDF Icon

    Report

  • 51 Pages
  • August 2023
  • Region: United States
  • BioIntel360
  • ID: 5734114
According to the publisher, United States gene editing technology market size is expected to record a CAGR of 22.2% during 2023-2027 to reach US$1.155 billion by 2027, increasing from US$0.424 billion in 2023. Over the last five years, the sector has recorded a CAGR of 28.4% to reach US$0.330 billion in 2022.

This report provides an in-depth data-centric analysis of the emerging opportunities in the gene editing industry. It covers a detailed view of market size and forecast across various segments such as gene editing technologies (CRISPR, meganucleases, TALENs, and ZFN), by products, delivery method, disease/disorders, and application.

This databook is a part of the title “Global Gene Editing Technology Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update”.

Scope

This report provides an in-depth, data-centric analysis of the United States gene editing market 2018-2027. Below is a summary of key market segments:

By Technology

  • CRISPR CAS 9
  • TALENs
  • ZFN
  • Others (Meganucleases)

By CRISPR PRODUCTS

  • Kits & Enzymes
  • Cell lines & Antibodies
  • Others (Plasmid, Controls)

By TALENs PRODUCTS

  • Kits & Enzymes
  • Cell lines & Antibodies
  • Others (Plasmid, Controls)

By ZFNs PRODUCTS

  • Kits & Enzymes
  • Cell lines & Antibodies
  • Others (Plasmid, Controls)

By Meganucleases PRODUCTS

  • Kits & Enzymes
  • Cell lines & Antibodies
  • Others (Plasmid, Controls)

By Delivery Method

  • Ex-vivo
  • In-vivo

By Disease/Disorders

  • Cancer
  • Blood Disorders (beta-thalassemia and sickle cell disease)
  • Blindness
  • Respiratory Disease (COVID-19 & Cystic fibrosis)
  • Others (AIDS, Huntington’s disease, Muscular dystrophy)

By Application

  • Drug Development
  • Diagnostics
  • Plant Gene Editing
  • Others (Animal Gene Editing)

By End-User

  • Pharmaceutical and Biopharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organisations
  • Academic Institutes and Research Centres

Reasons to buy

  • In-depth understanding of gene editing market dynamics: Understand market opportunity, industry dynamics, key trends, and drivers across different market segments and sub-segments of the industry in United States.
  • Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.
  • Get market share analysis by end users: Get a detailed analysis across different end users such as pharmaceutical, biotechnology companies, academic & research institutes, and contract research organisations.

Table of Contents

1 United States Gene Editing Technology Market Size and Forecast, 2018-2027
2 Gene Editing Technology Market Size by Technology, 2018-2027
2.1 United States Gene Editing Technology Market Share by Technology (%), 2018-2027
2.2 Gene Editing Technology Market Size and Forecast by CRISPR, 2018-2027
2.3 Gene Editing Technology Market Size and Forecast by TALENs, 2018-2027
2.4 Gene Editing Technology Market Size and Forecast by ZFNs, 2018-2027
2.5 Gene Editing Technology Market Size and Forecast by Meganucleases, 2018-2027
3 Gene Editing Technology Market Size by CRISPR Product, 2018-2027
3.1 Gene Editing Technology Market Share by CRISPR Product (%), 2018-2027
3.2 Gene Editing Technology Market Size and Forecast by Vector Based Cas9, 2018-2027
3.3 Gene Editing Technology Market Size and Forecast by DNA Free Cas9, 2018-2027
3.4 Gene Editing Technology Market Size and Forecast by Libraries & Antibodies, 2018-2027
3.5 Gene Editing Technology Market Size and Forecast by gRNA Design and Vector Construction, 2018-2027
3.6 Gene Editing Technology Market Size and Forecast by Cell Lines & Engineering, 2018-2027
3.7 Gene Editing Technology Market Size and Forecast by Others (Plasmid, Controls), 2018-2027
4 Gene Editing Technology Market Size by TALENs Product, 2018-2027
4.1 Gene Editing Technology Market Share by TALENs Product (%), 2018-2027
4.2 Gene Editing Technology Market Size and Forecast by Kits & Enzymes, 2018-2027
4.3 Gene Editing Technology Market Size and Forecast by Cell lines & Antibodies, 2018-2027
4.4 Gene Editing Technology Market Size and Forecast by Others (Plasmid, Controls), 2018-2027
5 Gene Editing Technology Market Size by ZFNs Product, 2018-2027
5.1 Gene Editing Technology Market Share by ZFNs Product (%), 2018-2027
5.2 Gene Editing Technology Market Size and Forecast by Kits & Enzymes, 2018-2027
5.3 Gene Editing Technology Market Size and Forecast by Cell lines & Antibodies, 2018-2027
5.4 Gene Editing Technology Market Size and Forecast by Others
6 Gene Editing Technology Market Size by Meganucleases Product, 2018-2027
6.1 Gene Editing Technology Market Share by Meganucleases Product (%), 2018-2027
6.2 Gene Editing Technology Market Size and Forecast by Kits & Enzymes, 2018-2027
6.3 Gene Editing Technology Market Size and Forecast by Cell lines & Antibodies, 2018-2027
6.4 Gene Editing Technology Market Size and Forecast by Others (Plasmid, Controls), 2018-2027
7 Gene Editing Technology Market Size by Delivery Mode, 2018-2027
7.1 Gene Editing Technology Market Share by Delivery Mode (%), 2018-2027
7.2 Gene Editing Technology Market Size and Forecast by Ex-vivo, 2018-2027
7.3 Gene Editing Technology Market Size and Forecast by In-vivo, 2018-2027
8 Gene Editing Technology Market Size by Diseases/Disorders, 2018-2027
8.1 Gene Editing Technology Market Share by Disease/Disorders (%), 2018-2027
8.2 Gene Editing Technology Market Size and Forecast by Cancer, 2018-2027
8.3 Gene Editing Technology Market Size and Forecast by Blood Disorders, 2018-2027
8.4 Gene Editing Technology Market Size and Forecast by Blindness, 2018-2027
8.5 Gene Editing Technology Market Size and Forecast by Respiratory Disease, 2018-2027
8.6 Gene Editing Technology Market Size and Forecast by Others, 2018-2027
9 Gene Editing Technology Market Size by Application, 2018-2027
9.1 Gene Editing Technology Market Share by Application (%), 2018-2027
9.2 Gene Editing Technology Market Size and Forecast by Drug Development, 2018-2027
9.3 Gene Editing Technology Market Size and Forecast by Diagnostics, 2018-2027
9.4 Gene Editing Technology Market Size and Forecast by Plant Gene Editing, 2018-2027
9.5 Gene Editing Technology Market Size and Forecast by Animal Gene Editing, 2018-2027
10 Gene Editing Technology Market Size by End Users, 2018-2027
10.1 Gene Editing Technology Market Share by End User (%), 2018-2027
10.2 Gene Editing Technology Market Size and Forecast by Pharmaceutical and Biopharmaceutical Companies, 2018-2027
10.3 Gene Editing Technology Market Size and Forecast by Biotechnology Companies, 2018-2027
10.4 Gene Editing Technology Market Size and Forecast by Contract Research Organisations, 2018-2027
10.5 Gene Editing Technology Market Size and Forecast by Academic Institutes and Research Centres, 2018-2027

Methodology

Loading
LOADING...

Table Information